Cargando…
Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma
Pathologic c-Myc expression is frequently detected in human cancers, including Merkel cell carcinoma (MCC), an aggressive skin cancer with no cure for metastatic disease. Bromodomain protein 4 (BRD4) regulates gene transcription by binding to acetylated histone H3 lysine 27 (H3K27Ac) on the chromati...
Autores principales: | Sengupta, Deepanwita, Kannan, Aarthi, Kern, Malan, Moreno, Mauricio A, Vural, Emre, Stack, Brendan, Suen, James Y, Tackett, Alan J, Gao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622756/ https://www.ncbi.nlm.nih.gov/pubmed/25941994 http://dx.doi.org/10.1080/15592294.2015.1034416 |
Ejemplares similares
-
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth
por: Kannan, Aarthi, et al.
Publicado: (2015) -
A Proteomic Study of Human Merkel Cell Carcinoma
por: Shao, Qiang, et al.
Publicado: (2013) -
MYC protein stability is negatively regulated by BRD4
por: Devaiah, Ballachanda N., et al.
Publicado: (2020) -
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015) -
Bromodomain Protein Brd4 Plays a Key Role in Merkel Cell Polyomavirus DNA Replication
por: Wang, Xin, et al.
Publicado: (2012)